Back

Protective near-germline antibodies to malaria elicited by RTS,S/AS01E vaccination in African infants

Bloch, E.; Devys, F.; Cannac, F.; Jain, M.; Broadbent, K.; Sanchez, C.; Lee, W.-H.; Jairoce, C.; Aide, P.; Campo, J. J.; Macia, D.; Carolis, C.; Wilson, I. A.; Ward, A. B.; Amino, R.; Moncunill, G.; Dobano, C.; Molinos-Albert, L. M.

2026-10-05 immunology
10.64898/2026.10.01.755937 bioRxiv
Show abstract

Malaria is a leading cause of childhood mortality, yet infant immune responses to vaccination remain poorly understood. Here, we characterize 88 monoclonal antibodies (mAbs) directed against the Plasmodium falciparum circumsporozoite protein cloned from African infants immunized with the RTS,S/AS01E malaria vaccine, identifying potent antiparasitic mAbs exhibiting molecular features resembling those observed in adults and minimal somatic hypermutation. Importantly, germline-reverted variants of four mAbs inducing sterile protection in vivo maintained high binding affinity and Fab-dependent parasite killing. Structural analyses revealed that a few amino acid replacements drive homotypic helical assemblies, fine-tuning parasite inhibition and protective efficacy. Thus, despite maturational constraints of early life, infants can generate potent antimalarial antibodies in a near-germline configuration, informing next-generation vaccine development for this vulnerable group.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.